- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
Q
DGX
Quest Diagnostics Inc
208.62
1.19+0.57%Opening12:02 02/24 EST
OPEN/PREV CLOSE207.95/207.43
TODAY RANGE206.36-209.42
VOL204.66K
MARKET CAP22.95B
52 WEEK RANGE155.09-213.20
AVG VOL (3M)1.03M
% TURNOVER0.19%
TURNOVER--
P/E (TTM)23.86
% RANGE1.48%
EPS(TTM)8.74
P/E(FORWARD)21.84
P/B3.201
BVPS65.18
DIVIDEND3.440
P/S2.080
BETA--
DIV YIELD1.65%
FREE FLOAT MKT CAP22.84B
SHARES OUTSTANDING110.00M
NEXT EARNINGS04/20-04/24
FREE FLOAT109.50M
LOT SIZE1
EX-DATE04/06/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·46m ago
How Investors May Respond To Quest Diagnostics (DGX) Earnings Beat, Higher Dividend And Expansion Plans
Seeking Alpha·5d ago
Here are the major earnings after the close Thursday
Seeking Alpha·6d ago
Dividend picks: 20 large-cap defensive stocks outperforming the market in 2026
Simply Wall St·02/17 00:29
Evaluating Quest Diagnostics (DGX) After Dividend Hike Strong Earnings Guidance And Expanded Buyback
Seeking Alpha·02/15 14:05
Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus
Simply Wall St·02/15 12:33
Quest Diagnostics (DGX) Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?
Seeking Alpha·02/13 23:33
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Seeking Alpha·02/13 14:04
Dividend Roundup: Chevron, Microsoft, Meta, Hyatt, and more
Simply Wall St·02/12 17:34
Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology
Dow Jones·02/12 13:34
Quest Diagnostics Is Maintained at Outperform by Mizuho
Benzinga·02/12 13:23
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235
TipRanks·02/12 12:41
Quest Diagnostics price target raised to $235 from $210 at Mizuho
Same Industry
Name/Symbol
Change%
Price